英文别名 |
Entecavir;Entecavi;entecavir Baraclude;2-Amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one,;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one;Entecavir-d2;Baraclude;BMS200475;SQ34676;UNII-NNU2O4609D;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;BMS 200475;entecavir (anhydrous);NNU2O4609D;SQ 34676;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one;anhydrous entecavir;6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecycl;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one;Q418586;2-amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one;Entecavir [INN];S5246;SCHEMBL28648;SQ 34,676;142217-69-4;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one;CHEBI:473990;BRD-K08206212-001-01-2;DTXSID4046446;ENTECAVIR [MI];2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one;6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl];CHEMBL713;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;ENTECAVIR (MART.);6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;ENTECAVIR [WHO-DD];2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-1H-purin-6-one;2-amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one;SCHEMBL15198001;SQ-34676;NCGC00164563-09;DTXCID2026446;QDGZDCVAUDNJFG-FXQIFTODSA-N;2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one;NCGC00164563-01;Entecavir (INN);AKOS015854916;AKOS025312554;MFCD00907887;9-[(1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]guanine;6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, [1S-(1a,3a,4ss)]-; BMS 200475; Baraclude; Entecavir; SQ 34676;(1R,3S,4S)-Entecavir;DB00442;NCGC00164563-04;ENTECAVIR (USP MONOGRAPH);CCG-267218;BDBM50248008;BMS-200475;UNII-5968Y6H45M;ENTECAVIR MONOHYDRATE (EP MONOGRAPH);ENTECAVIR [HSDB];CS-3160;CAS-142217-69-4;6H-Purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-;AR-270/43507901;D07896;Entecavir [USAN:INN];E0899;AKOS015920226;HY-13623;NCGC00164563-13;GS-6386;2-AMINO-9-((1S,3R,4S)-4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL)-1H-PURIN-6(9H)-ONE;AC-1593;J05AF10;HSDB 7334;BMS 200475-01;NCGC00164563-06;BRD-K08206212-002-01-0;2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydro... |